{"SPADE_UN_08116": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 7001924 B2", "Patent Link": "http://www.lens.org/lens/patent/US_7001924_B2", "Patent Type": "Granted Patent", "Publication Date": "2006-2-21", "Family Info": "EP1435932A2,EP1435932A4,US20030134904,WO2003024407A2,WO2003024407A3", "Patent Title": "Inhibitors of RNase P proteins as antibacterial compounds.", "Abstract": "The present invention features compounds useful for inhibiting RNase P activity. These compounds can be used as therapeutics for treating or preventing a variety of bacterial infections. The compounds belong to several classes including mono- and bis-guanylhydrazones, guanylhydrazone mimetics, and benzothiazolium compounds. Exemplary compounds are compounds of formula I: \nYâ€”(NRâ€²)kâ€”U1â€”(NRâ€³)Iâ€”Aâ€”(NR1)mâ€”U2â€”(NR2)nâ€”Zâ€ƒâ€ƒI with substituents as described herein."}], "Sequence Information": {"SPADE ID": "SPADE_UN_08116", "Sequence": "LRGEREFRKVRRIGLVVSKKTLKHAVKRNRARRRVREALRTMPPELRAILMLNPGVLTVPFPELQAALAQALQRGAG", "Sequence Length": 77, "Peptide Name": "Sequence 113 from Patent US 7001924", "Source": "Synthetic construct", "Biological Activity": ["Antimicrobial"], "Frequent Amino Acids": "RLA", "Absent Amino Acids": "CDOUWY", "Basic Residues": 20, "Acidic Residues": 5, "Hydrophobic Residues": 38, "Polar Residues": 45, "Positive Residues": 20, "Negative Residues": 5, "Mass": 8763.41, "PI": 12.0, "Net Charge": 15, "Hydrophobicity": -0.36, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_18520", "Similarity": 0.9795918367346939, "Sequence": "LRGEREFRRIGLVVSKKTLKHAVKRNRARRRVRELLRAILLAQALQRGA"}]}}}